We Value the Contribution of Our Current and Future Strategic Partners 

Oncotherapy Solutions, LLC will be financially stable and viable through two strategic decisions: The initial phase will depend on SBIR grants from the National Cancer Institute and from private investors. The second phase will depend on Licensing & Partnerships with other biotech and pharmaceutical companies as well as from product sales.

The company is seeking pharmaceutical and biotechnology partners to work with to advance its preclinical programs and move lead drug conjugates to clinical trials.  Our drug conjugates are potent and safer than standard of care.

Management has tremendous previous experience in drug development and drug delivery, having previously worked on drug candidates that are currently in the market or in late clinical trials.

Management has strong background in biotech project management and business administration as well as excellent publication record and patent portfolio.

Our 2 preclinical programs are carefully-designed and our drug conjugates have a great potential in reaching the market.